Ozempic Side Effects: What Is Common, What Is Serious and What to Track

    Short answer

    The most common Ozempic side effects on its FDA label are nausea, vomiting, diarrhea, stomach pain and constipation. In type 2 diabetes trials, nausea was reported by 15.8% to 20.3% of adults versus 6.1% on placebo, mostly while the dose was being increased. Severe stomach pain or allergic swelling needs urgent care.

    Most Ozempic side effects involve the stomach, and most reports of nausea, vomiting and diarrhea came while the dose was being increased. This page walks through how often each one happened in clinical trials, which risks are serious, and when to contact your prescriber. Everything here comes from the Ozempic prescribing information, revised May 2026.

    The label in four points

    The short version, from the Ozempic prescribing information, revised 05/2026.

    Stomach effects lead the list

    In placebo-controlled trials, nausea affected about 16% to 20% of people on Ozempic, compared with about 6% on placebo. Vomiting, diarrhea, stomach pain and constipation were the other common effects. Overall, stomach side effects were reported by about 33% to 36% of people on Ozempic versus about 15% on placebo.

    They tend to happen during dose increases

    The label says most nausea, vomiting and diarrhea occurred during dose escalation. Ozempic also slows how fast the stomach empties, which helps explain these effects. Your prescriber sets your schedule and is the right person to ask about how you are feeling.

    Most people kept going

    About 3% to 4% of people on Ozempic stopped treatment because of stomach side effects in those trials, compared with 0.4% on placebo. That still matters for the people it affects, which is why the label lists when to seek care.

    Some risks are serious

    The label carries a boxed warning about thyroid C-cell tumors and lists warnings for pancreatitis, gallbladder problems, kidney injury, low blood sugar and more. Those are covered below, with the symptoms the label says to act on.

    Common side effects and how often they happened

    The first five rows are the label's Table 1: side effects reported by at least 5% of people on Ozempic, and more often than on placebo, in the placebo-controlled trials in adults with type 2 diabetes. The other rows come from the label's text on the same trials. The doses in the column headings are the label's trial arms, not a recommendation.

    Side effectPlaceboOzempic 0.5 mgOzempic 1 mg
    Nausea6.1%15.8%20.3%
    Vomiting2.3%5%9.2%
    Diarrhea1.9%8.5%8.8%
    Stomach pain4.6%7.3%5.7%
    Constipation1.5%5%3.1%
    Indigestion (dyspepsia)1.9%3.5%2.7%
    Burping (eructation)0%2.7%1.1%
    Reflux (GERD)0%1.9%1.5%
    Gallstones (cholelithiasis)0%1.5%0.4%

    Nausea

    Nausea was the most common side effect, reported by 15.8% and 20.3% of people at the two doses studied, compared with 6.1% on placebo. It was most often reported while the dose was being increased.

    Vomiting and diarrhea

    Vomiting was reported by 5% and 9.2% of people on Ozempic, compared with 2.3% on placebo. Diarrhea was reported by 8.5% and 8.8%, compared with 1.9%. Losing fluids from vomiting or diarrhea can affect the kidneys, which the label lists as a separate warning.

    Stomach pain and constipation

    Abdominal pain was reported by 7.3% and 5.7% of people on Ozempic, compared with 4.6% on placebo. Constipation was reported by 5% and 3.1%, compared with 1.5%. Severe stomach pain that does not go away is different, and is covered under serious risks below.

    Less common stomach effects

    Indigestion, burping, gas, acid reflux and gastritis were each reported by fewer than 5% of people on Ozempic. Burping, listed on the label as eructation, was reported by 2.7% and 1.1% of people, compared with none on placebo.

    Other effects on the label

    Fatigue, changes in taste and dizziness were also linked with Ozempic at frequencies above 0.4%. Heart rate rose by an average of 2 to 3 beats per minute. Gallstones were reported by 1.5% and 0.4% of people at the two doses, and by no one on placebo.

    Serious risks on the label

    These events are uncommon, but they are why a new or unusual symptom should not always be put down to the medicine.

    Boxed warning: thyroid C-cell tumors

    In rodent studies, semaglutide caused thyroid C-cell tumors, and it is unknown whether it does this in people. Ozempic should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with MEN 2. The label says to report a lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath.

    Pancreatitis

    Acute pancreatitis has been reported with GLP-1 medicines, including Ozempic. The label describes persistent severe stomach pain, sometimes spreading to the back, with or without vomiting. That symptom needs prompt medical attention.

    Gallbladder problems

    The label lists acute gallbladder disease, including gallstones and inflammation of the gallbladder. Pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools are signs to report.

    Kidney injury from fluid loss

    Severe vomiting or diarrhea can cause dehydration, and the label warns this can lead to acute kidney injury. Staying in touch with your prescriber when stomach effects are strong is part of the label's guidance.

    Low blood sugar, eye changes and allergic reactions

    Low blood sugar is more likely when Ozempic is used with insulin or a sulfonylurea. In the trial that added Ozempic to basal insulin, blood sugar confirmed at or below 56 mg/dL with symptoms, or severe low blood sugar, was reported by 8.3% to 10.7% of people, compared with 5.3% on placebo. The label also lists diabetic retinopathy complications and serious allergic reactions, and notes a risk of food or liquid entering the lungs during anesthesia or deep sedation, so tell your care team you take Ozempic before any procedure.

    When to call your prescriber or get emergency care

    This list follows the warnings and Medication Guide in the Ozempic label. It is not a complete list and it is not medical advice: if something feels wrong, call.

    Get emergency help for

    Signs of a serious allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing or a very fast heartbeat, need emergency care. So does severe stomach pain that will not go away.

    Call your prescriber about

    Contact your prescriber about any of these:

    • Nausea, vomiting or diarrhea that is severe or will not go away, or signs of dehydration.
    • Pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools, which can be gallbladder signs.
    • Shakiness, sweating, dizziness, a fast heartbeat, hunger, headache, blurred vision, confusion or irritability, which can mean low blood sugar, especially with insulin or a sulfonylurea.
    • Any change in your vision, if you have type 2 diabetes.
    • A lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

    Before any procedure

    Tell the doctors and care team that you take Ozempic before surgery or any procedure that uses anesthesia or sedation. The label asks patients to share this so the team can plan.

    Questions about your dose

    Questions about your dose, schedule or a missed shot belong with your prescriber, and your label has the official missed-dose instructions. This page does not give dosing advice.

    How to report a side effect

    The label gives two contacts for reporting a suspected side effect: Novo Nordisk at 1-888-693-6742, or the FDA's MedWatch program at 1-800-FDA-1088.

    Why stomach effects are so common

    Understanding why an effect happens helps you describe it accurately to your prescriber.

    Slower stomach emptying

    The label states that Ozempic delays gastric emptying, meaning food stays in the stomach longer. That slower emptying is linked with fullness, nausea and other stomach effects.

    Dose increases are the peak time

    Most nausea, vomiting and diarrhea in the trials happened during dose escalation. In a trial comparing two higher doses, stomach effects were slightly more frequent at the higher dose: 34% on 2 mg versus 30.8% on 1 mg.

    Weekly dosing means effects can linger

    Semaglutide has a half-life of about 1 week, so each dose stays active for days. That is one reason some people notice symptoms follow a pattern across the week. The semaglutide half-life calculator shows what a 1-week half-life looks like.

    Ozempic and Wegovy share an active ingredient

    Both contain semaglutide, but Ozempic is approved for type 2 diabetes and the trial numbers on this page come from its label. Wegovy has its own label and its own trial data, covered in Wegovy side effects.

    From the makers of this guide

    Keep a simple side effect log

    The label gives trial averages. Your prescriber needs your version: what you felt, how strong it was, and when.

    1. 01

      Note what, when and how strong

      The side-effect tracker has built-in GLP-1 symptoms grouped by area, such as injection site, digestive and head and nerves, plus your own, each saved by day with how severe it was. A short daily check-in asks about food noise, side effects and mood, and you can add questions such as energy and sleep.

    2. 02

      Symptoms beside your shot days

      Your side-effect trend chart sits on the Dose tab beside your Ozempic shot history and estimated level chart, so a pattern like nausea on the day after each shot is easy to spot.

    3. 03

      Meals you can look back on

      Log meals by photo scan, barcode or search in Nutrition, then look back to notice which foods tend to sit well on harder days.

    4. 04

      See which weeks felt different

      After a few weeks, the trend chart shows which stretches were rough and which were easy, which turns a vague feeling into something specific you can describe.

    Download on the App StoreGet it on Google Play

    Bring your log to your next appointment

    A side effect log does the most good in the conversation with your prescriber.

    A report your prescriber can read in a minute

    Pep AI builds a PDF report of your doses, injection sites, weight and daily meal totals. Show it on your phone or send it ahead of the visit.

    Questions worth asking

    Ask whether a symptom pattern is expected, what to watch for and when to call between visits. Your prescriber decides what, if anything, should change.

    Keep going between visits

    Logging takes a few seconds a day once the routine is set, and the next report is ready whenever the next appointment comes around.

    More reading on Pep AI

    For a broader overview, read GLP-1 side effects. For nausea in particular, GLP-1 nausea covers what the labels say, and the Ozempic tracker shows how shot logging works.

    Key takeaways

    • Nausea was reported by 15.8% to 20.3% of adults on Ozempic in type 2 diabetes trials, versus 6.1% on placebo.
    • Most nausea, vomiting and diarrhea happened during dose escalation.
    • About 3% to 4% stopped Ozempic because of stomach effects, versus 0.4% on placebo.
    • Ozempic carries the boxed thyroid C-cell tumor warning, and its label lists pancreatitis, gallbladder problems, kidney injury and low blood sugar.
    • Dose, schedule and missed-dose questions belong with your prescriber and your label.

    Know which side effects are yours.

    Pep AI logs your Ozempic shots, symptoms with severity, meals and weight, and makes a PDF of your doses, sites, weight and meal totals. Download Pep AI on iPhone or Android.

    Download on the App StoreGet it on Google Play

    Frequently asked questions

    Keep reading

    Sources

    1. Ozempic (semaglutide) injection prescribing information and Medication Guide, Novo Nordisk / FDA (revised 05/2026)
    2. MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    This page summarizes the Ozempic prescribing information (revised 05/2026). It is general information, not medical advice, and does not replace your prescriber or pharmacist. Pep AI is not affiliated with or endorsed by Novo Nordisk. If a symptom is severe, getting worse or worrying you, contact your healthcare provider. In an emergency, call 911.

    Published by the Pep AI team · Updated November 2026